Clinical Oversight & Safety Prescribing is done through physicians employed by Colchis Medical Services PC, with asynchronous or synchronous evaluation, depending on the state
Anyone taking medications, managing diagnosed health conditions, pregnant or nursing, or with health concerns is appropriately evaluated by healthcare providers when considering GLP-1 medication use
Most providers recommend starting semaglutide about one week after your last tirzepatide injection, aligning with your normal weekly injection schedule
Sensitivity analyses removing (1) IIH-WOP and (2) patients with migraine did not significantly change the overall results or impact of single variables
The global semaglutide market size was estimated at approximately USD 28.43 billion in 2024 and is projected to reach an astounding USD 93.6 billion by 2035, growing at an impressive CAGR of over 10%
If you have any of these, discuss them with your prescriber before starting treatment: Gastroparesis